BCG

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Evaluating the Safety and Immunogenicity of MTBVAC

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b

A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates

Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases

Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction

Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa

Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer

Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study

A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi

COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement

Aerosol BCG Challenge Trial in Healthy UK Adults

BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder